CLINICAL TRIALS, MARKET ACCESS, MARKET ENTRY, MARKET RESEARCH, INVIMA REGULATORY REGISTRATION, LEGAL REPRESENTATION, AND DISTRIBUTOR SEARCH IN COLOMBIA FOR DRUGS, MEDICAL DEVICES, DIETARY SUPPLEMENTS, COSMETICS, FOOD, ALCOHOLIC BEVERAGES, AND PERSONAL HYGIENE PRODUCTS
"This decision to engage LATAM Market Access was made to increase our focus and visibility within South America. It is of the utmost importance that we partner with distributors that have influence and a good track record within the Colombian market."
“Traditional clinical trials in the U.S. can take years and millions — or even billions — of dollars. We believe we have the scientist, the technology, the physicians, and the lab partners that are necessary to get this trial done faster in Colombia.”
Imagine if you could access a multi-billion market with a 50-million population. With a top performing universal health system. With OECD membership that ensure alignment of its legislation, policies and practices to global first-world standards. With a free-trade agreement with the US, the EU, and the Pacific Alliance (a future single economic and regulatory market for Mexico, Peru, Chile, and Colombia). With a fast and efficient regulatory pathway —acceptance of USA, EU, Canada, Japan, and Australia free-sale certificates.
Foreign companies struggle to find a cost-effective clinical trial site or to gain market share in Colombia —and the rest of Latin America. They are unfamiliar with the region and lack in-house experts to operationalize a successful clinical trial, market access, or regulatory strategy.
We bring Colombia —and Latin America— closer to you. We provide you with clinical trial, market access, and regulatory offerings so that you can achieve long-term sales growth in Colombia.
Our regulatory team is based in Colombia and includes members who worked for INVIMA for over 20 years. They have processed and approved hundreds of regulatory dossier files.
Julio is a savvy leader with an indelible reputation for delivering inventive and growth-focused business strategies. He is recognized for his entrepreneurial spirit, grit and vision that build the foundation for successful ventures. Julio worked for large global telecom companies and was the co-founder and president of a real estate investment firm in Orlando, FL. Julio has a B.S. degree in electronics engineering and a masters in business administration (MBA).
Monica leads the company's operations, logistics, accounting, human resources and general corporate and project-related administrative matters. Monica has worked for global companies such as Alcatel-Lucent and Toshiba. She has a B.S. degree in computer sciences and graduate studies in business management.
Osvaldo helps promote Colombia's opportunities to manufacturers of regulated products looking to expand their market to Latin America. Osvaldo has worked with hundreds of life science companies to help them formulate their market entry and clinical trial strategy in Colombia. He has a double B.S. degree in international business and political sciences.
David is professor of innovation and entrepreneurship at the biomedical engineering department of Universidad de los Andes in Bogota, Colombia. He has a degree in mechanical engineering and has worked for over 25 years at global companies such as Schlumberger and GE in various parts of the world. At GE he was at the heart of Silicon Valley, was involved in several ventures, in the development of advanced IT technologies, and led a division focused on defense products. David was also the CEO of a medical device company in Colombia.
Cris is our lead clinical trial project manager. She has a microbiology degree from Javeriana University —one of the top universities in Colombia and in Latin America; she worked for Quintiles —the leading CRO in the world; she has a master’s degree on epidemiology from Universidad del Norte —the leading university in Colombia’s Caribbean coast. She was also the research director at COFCA —one of the leading ophthalmology research centers in Colombia. Cris has worked in a number of study protocols that have been approved for trials and have successfully managed these trials.